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ABSTRACT Syringomas are benign tumors of adnexal origin, and eruptive syrin-
goma is an extremely rare subtype. In this paper, we present a case of a unusual 
occurrence of eruptive syringoma in 66-year old woman that includes clinical and 
pathohistological findings and the review of the clinical picture, diagnosis, and 
treatment options.
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INTRODUCTION
Syringomas are benign tumors of adnexal origin. 
They were initially described by Kaposi in 1872 as 
lymphangioma tuberosum multiplex (1). Syringomas 
typically present as multiple soft or firm, skin-colored 
or yellow papules measuring 1 to 5 mm in diameter 
(2), that tend to appear on the eyelids in middle-aged 
women (3).
A classification of syringomas was proposed by 
Friedman and Butler. According to their clinical fea-
tures and associations with other medical conditions, 
syringomas can be classified as one of four principal 
variants: localized form, familial form, form associat-
ed with Down syndrome, and generalized form that 
encompasses eruptive syringomas (4).
Eruptive syringoma is a rare variant of syringoma 
that usually appears before or during puberty (5). 
Herein we present an unusual case of eruptive syrin-
goma in elderly female patient.
CASE REPORT
A 66-year old woman presented with multiple skin 
lesions appearing on the face, neck, and axillar and 
cubital areas in successive crops that developed over 
a 15-year period. She reported pruritus in the affected 
areas following perspiration as well as aggravation of 
lesions after exposure to heat. She was initially treated 
with local corticosteroid cream, which made lesions 
less erythematous and less pruritic but still persistent. 
She denied a familial history of such or similar lesions. 
The patient’s past medical history included hypo-
thyreosis and hypertension, for which she had been 
treated with lisinopril and levothyroxine.
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Physical examination revealed multiple flat-
topped papules 1-3 mm in diameter and symmetri-
cally distributed, on the forehead, lower third of the 
face, neck, and axillary and cubital areas, ranging in 
color from flesh color to pink. The lesions on the fore-
head and neck were surrounded by erythematous 
halos. The lesions were symmetrical in all parts of the 
body (Figure 1). 
The initial clinical diagnosis was flat warts, and 
skin biopsy of a small papule on the cubital area was 
obtained. Histological examination of the specimen 
showed multiple ducts in superficial dermis. The 
ducts were formed by two layers of epithelial cells 
and were filled with amorphous eosinophilic material. 
Some of ducts had elongated tails of epithelial cells, 
producing the characteristic comma-shaped appear-
ance (Figure 2). Clinical and histological findings were 
compatible with diagnosis of eruptive syringoma.
An additional patch test was performed using 
a baseline series of patch test allergens (European 
Standard Series), which yielded a negative result for 
all allergens tested.
The patient refused all suggested treatment op-
tions, including topical retinoids and cryosurgery.
DISCUSSION
Syringomas are commonly classified as benign 
neoplasms derived from the eccrine duct (3). The 
presence of eccrine enzymes such as succinic hydrog-
enase, phospohorylase, and leucine aminopeptidase 
provides further evidence of their eccrine rather than 
apocrine differentiation, as originally thought (6). 
Eruptive syringoma is a rare variant first described by 
Jacquet and Darier in 1887. It occurs more frequently 
among women.
Clinically they appear as multiple, small, firm, and 
skin-colored or slightly yellow soft papules, 1-3 mm 
in diameter. They typically present in a bilateral, sym-
metrical distribution, but there have been reports 
of unilateral, unilateral nevoid, bathing trunk, and 
generalized distribution. Eruptive syringomas most 
commonly involve the face, anterior surfaces of the 
neck, chest, abdomen, upper extremities, and genita-
lia. There are some differences between prepubertal 
and postpubertal distribution. The neck and anterior 
trunk are more frequent sites before the age of 15 
years. After 15 years of age, the apocrine localization 
is infrequent (7). 
The eruptions are generally asymptomatic, al-
though pruritus has been reported in some cases, es-
pecially in conjunction with perspiration. Vulvar syr-
ingomas were reported as an unusual cause of pru-
ritus (8,9). The pathogenesis of eruptive syringomas 
still remains unclear. Syringoma is currently believed 
to be a neoplastic process.
Figure 2. Eruptive syringoma demonstrating ducts 
formed by two layers of epithelial cells and filled with 
eosinophilic material, with elongated tails of epithe-
lial cells; (a) hematoxylin and eosin (H&E) stain ×40; 
(b) H&E stain ×120.
Figure 1. Multiple pink papules with eritematous hal-
los in the neck region, 1-3 mm in diameter.
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Guitart et al. proposed the new term “syringoma-
tous dermatitis“. They reported 2 cases of maculopap-
ular eruptions with histologic findings of lymphocytic 
infiltrate involving intraepidermal and dermal por-
tions of the ecrine ducts which evolved during next 
few months into tortuous syringomatous prolifera-
tion of ductal structures (10). Garrirdo-Ruiz et al. re-
ported a distinct eruptive syringoma over the pubic 
and inguinal area which had developed after inten-
sive waxing (11). 
Similar syringomatous changes have been re-
ported in association with alopecia areata, prurigo 
nodularis, and radiation dermatitis. In these cases, 
the initial inflammatory processes may precede the 
appearance of eruptive syringomas (12,13,14,15). 
The higher incidence of syringoma in women, 
proliferation of lesions at puberty, exacerbation dur-
ing pregnancies and enlargement during the pre-
menstrual period may suggest a hormonal role in 
some cases (8). 
The clinical diagnosis of eruptive syringoma is 
relatively difficult. Clinically they may be mistaken 
for acne vulgaris, sebaceous hyperplasia, milia, lichen 
planus, eruptive xantoma, urticarial pigmentosa, hi-
drocystoma, plane warts, granuloma annulare, and 
hystiocytosis (16,17). 
Establishing the diagnosis of syringoma is based 
on histological examination. The haematoxylin and 
eosin stain shows the presence of multiple small ducts 
and epithelial cords within the dermis. The ducts are 
lined by two rows of flattened epithelial cells, the out-
er layer bulging outward to create a comma-like tail 
(7). Clear cell syringoma is a rare histological variant 
of syringoma which cannot be clinically separated 
from common variants. This variant is formed by cells 
that have a pale cytoplasm as a result of glycogen ac-
cumulation and is strongly associated with diabetes 
mellitus (18,19). 
Our case is unique for several reasons. The lo-
calization of syringoma in our patient was the face, 
neck, axillae, and antecubital area, which is charac-
teristic for prepubertal localization. As mentioned 
earlier, apocrine localization in postpubertal patients 
is infrequent. We have found only one report of 
eruptive syringoma onset in the seventh decade of 
life (20). Our patient also had symptomatic eruptive 
syringoma with pruritus and erythema around the 
lesions. We did not find any inflammatory infiltrate 
in our biopsy or signs of contact sensibilization in a 
patch test. However, we took only one biopsy and it 
was performed at a “late stage” regarding a possible 
inflammatory phase. 
Some authors reported a possible relationship 
between medications and eruptive syringoma oc-
currence (20,21). In our case, the patient started her 
medication (lisinopril, levothyroxine) after the skin 
changes developed, so we could not establish such 
a connection.
The treatment of syringoma is performed for cos-
metic reasons. The goal of therapy for syringomas 
should be destruction of the tumor with minimal 
scarring and no recurrence. Treatment modalities 
have included dermabrasion, various methods of 
excision, cryosurgery, electrodesiccation, chemical 
peeling, and oral and topical retinoids (22,23,24). 
A recent report described a successful treatment 
of symptomatic eruptive syringomas with 1% topical 
atropine. The use of topical atropine resulted in the 
disappearance of the pruritus and a discrete reduc-
tion in the size of the lesions without any side effects 
(25). However, because syringomas are embedded 
within the dermis, complete removal is often impos-
sible. Any method of chemical or surgical destruction 
is associated with the risk of scarring.
CONCLUSION
Our case represents a distinctive clinical presenta-
tion of eruptive syringoma that should be considered 
in the differential diagnosis of papular dermatosis at 
any age.
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